BofA Securities Downgrades CureVac (CVAC) to Underperform
Tweet
Share
E-mail
Get Alerts CVAC Hot Sheet
Price: $4.66 --0%
Rating Summary:
1 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
1 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham downgraded CureVac (NASDAQ: CVAC) from Neutral to Underperform with a price target of $20.00.
For an analyst ratings summary and ratings history on CureVac click here. For more ratings news on CureVac click here.
Shares of CureVac closed at $21.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades SentinelOne Inc (S) to Hold on Valuation
- Maxim Group Downgrades cbdMD Inc. (YCBD) to Hold
- B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
